Newsroom

EQRx has announced that executives Alexis Borisy, Melanie Nallicheri, and Jami Rubin will participate in a fireside chat discussion at the Morgan Stanley 19th Annual Global Healthcare Conference.

Industry veteran brings more than 20 years of global government affairs and corporate communications experience as EQRx accelerates “new pharma” platform

EQRx, Inc. and CM Life Sciences III, Inc. (NASDAQ: CMLTU), a life science-focused special purpose acquisition company, or SPAC, sponsored by affiliates of Casdin Capital, LLC and Corvex Management LP, announced that they have entered into a definitive business combination agreement.

EQRx and AbCellera announced a collaboration agreement for the discovery and development of therapeutic antibodies, spanning several therapeutic areas, which will help to rapidly expand EQRx’s early-stage pipeline of novel medicines.

Mission advisory board to provide strategic input to advance EQRx’s mission of remaking medicine